BAFNAPH.NSライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (7 5月 2024 @ 18:59):

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company provides delayed and sustained release, chewable, and orally disintegrating tablets...

Stats
本日の出来高	20 203.00
平均出来高	7 690.00
時価総額	2.48B
EPS	INR0 ( 2024-02-11 )
次の収益日	( INR0 ) 2024-05-21
Last Dividend	INR0.600 ( 2013-09-19 )
Next Dividend	INR0 ( N/A )
P/E	21.97
ATR14	INR0.484 (0.46%)

ボリューム相関

長: 0.21 (neutral)

短: -0.23 (neutral)

Signal:(48.24) Neutral

Bafna Pharmaceuticals 相関

10 最も正の相関
BUTTERFLY.NS	0.955
CLNINDIA.NS	0.942
DIAMONDYD.NS	0.936
BAYERCROP.NS	0.935
FSC.NS	0.934
EASTSILK.NS	0.933
INDIAGLYCO.NS	0.93
TATVA.NS	0.929
ROLTA.NS	0.928
AJRINFRA.NS	0.927

10 最も負の相関
HARIOMPIPE.NS	-0.932
CIGNITITEC.NS	-0.921
CONTROLPR.NS	-0.92
SONATSOFTW.NS	-0.918
BECTORFOOD.NS	-0.91
KAYNES.NS	-0.91
CLSEL.NS	-0.91
GEEKAYWIRE.NS	-0.909
TARMAT.NS	-0.904
JMCPROJECT.NS	-0.901

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Bafna Pharmaceuticals 相関 - 通貨/商品

-0.71
( moderate negative )

-0.69
( moderate negative )

0.06
( neutral )

-0.81
( strong negative )

0.27
( neutral )

-0.80
( moderate negative )

Bafna Pharmaceuticals 財務諸表

Annual	2022
収益:	INR1.15B
総利益:	INR387.56M (33.60 %)
EPS:	INR4.79

FY	2022
収益:	INR1.15B
総利益:	INR387.56M (33.60 %)
EPS:	INR4.79

FY	2022
収益:	INR851.40M
総利益:	INR338.55M (39.76 %)
EPS:	INR2.17

FY	2021
収益:	INR712.18M
総利益:	INR257.62M (36.17 %)
EPS:	INR2.46

Financial Reports:

No articles found.

Bafna Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Bafna Pharmaceuticals Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.98 - low (32.33%) | Divividend Growth Potential Score: 2.71 - No dividend growth expected in the near future

Information

First Dividend	INR0.600	2013-09-19
Last Dividend	INR0.600	2013-09-19
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	INR0.600	--
Avg. Dividend % Per Year	0.00%	--
Score	1.01	--
Div. Sustainability Score	3.98
Div.Growth Potential Score	2.71
Div. Directional Score	3.34	--

Next Divdend (Est)
(2024-05-08)

INR0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

1.01

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0	0.00%
2019	INR0	0.00%
2020	INR0	0.00%
2021	INR0	0.00%
2022	INR0	0.00%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SOMANYCERA.NS	Dividend Junior	2023-08-18	Annually	23	0.39%
MOIL.NS	Dividend Knight	2023-09-08	Semi-Annually	14	2.38%
HDFCBANK.NS	Dividend Junior	2023-05-16	Annually	28	0.58%
BHANDARI.NS	Dividend Junior	2023-09-22	Annually	8	0.18%
RAJRATAN.NS	Dividend Junior	2023-07-27	Annually	4	0.12%
KIRLOSIND.NS	Dividend Junior	2023-08-03	Annually	17	0.72%
ENDURANCE.NS	Dividend Junior	2023-08-10	Annually	8	0.30%
ALBERTDAVD.NS	Dividend Junior	2023-08-02	Annually	8	1.24%
SUPRIYA.NS	Dividend Junior	2023-09-15	Annually	3	0.10%
NCLIND.NS	Dividend Junior	2023-09-15	Semi-Annually	18	1.25%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0735	1.500	8.53	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.145	1.500	9.50	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	5.17	1.000	9.20	9.20	[3 - 30]
operatingCashFlowPerShareTTM	4.44	2.00	8.52	10.00	[0 - 30]
freeCashFlowPerShareTTM	4.44	2.00	7.78	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.305	1.000	8.25	8.25	[0.2 - 0.8]
operatingProfitMarginTTM	0.0782	1.000	-0.436	-0.436	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.98

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	22.01	1.000	7.88	0	[1 - 100]
returnOnEquityTTM	0.145	2.50	9.68	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	4.44	2.00	8.52	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	4.44	2.00	8.52	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-2.17	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0685	1.000	-0.788	0	[0.1 - 0.5]
Total Score				2.71

Bafna Pharmaceuticals

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company provides delayed and sustained release, chewable, and orally disintegrating tablets. It also exports its products. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India.